feed,title,long_url,short_url
SeekingAlpha,Mallinckrodt down 11% on FDA rejection of terlipressin for type of kidney failure,https://seekingalpha.com/news/3613554,
SeekingAlpha,KalVista Pharmaceticals EPS misses by $0.01,https://seekingalpha.com/news/3613553,
